Endothelial cell proliferation and the formation of new vessels are strictly regulated by angiogenic factors (e.g., VEGF) that induce the activation of signal transduction pathways controlled by calcium dynamics. Using in vitro and in vivo experiments, we investigated the effect of calcium trifluoroacetate (CaTFAc), a complex, poorly dissociated salt that is characterized by its low toxicity, on angiogenesis. In vitro, CaTFAc inhibited VEGF-induced effects on endothelial cell proliferation. In two in vivo models of angiogenesis, a Matrigel plug in mice and a chick embryo chorioallantoic membrane, CaTFAc inhibited the VEGF-induced formation of new vessels. The exact mechanism of action is still under investigation, but in vitro experiments demonstrate that CaTFAc induced a reversible increase in the levels of intracellular calcium under basal conditions and prevented calcium signaling induced by VEGF. These results are the first to suggest that CaTFAc may be useful for the treatment of diseases caused by enhanced angiogenesis. (C) 2009 Elsevier Inc. All rights reserved.
机构:
Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
Agarwal, Isha
Karumanchi, S. Ananth
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
Howard Hughes Med Inst, Boston, MA 02115 USAHarvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
机构:
Univ Calif San Francisco, Dept Neurooncol, Brain Tumor Res Ctr, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Neurooncol, Brain Tumor Res Ctr, San Francisco, CA 94143 USA
机构:
Fondazione IRCCS Ist, Struttura Complessa Pediatria, Nazl Tumori, Milan, ItalyFondazione IRCCS Ist, Struttura Complessa Pediatria, Nazl Tumori, Milan, Italy